---
figid: PMC9688207__cells-11-03699-g004
pmcid: PMC9688207
image_filename: cells-11-03699-g004.jpg
figure_link: /pmc/articles/PMC9688207/figure/cells-11-03699-f004/
number: Figure 4
figure_title: ''
caption: 'The Notch signaling pathway in cancer stem cells. Abbreviations: ADAM/TACE—a
  disintegrin and metalloproteinase/tumor necrosis factor-alpha converting enzyme;
  Co-A—co-activator; Co-R—co-repressor; CSCs—cancer stem cells; CSL—CBF1, Suppressor
  of Hairless, Lag-1; EMT—epithelial-to-mesenchymal transition; MAM—mastermind; NEC—Notch
  extracellular subunit.; NEXT—Notch extracellular truncation; NICD—Notch intracellular
  domain; NTM—Notch transmembrane subunit (Created with BioRender.com (accessed on
  16 November 2022)).'
article_title: Cancer Stem Cells—The Insight into Non-Coding RNAs.
citation: Rut Bryl, et al. Cells. 2022 Nov;11(22):3699.
year: '2022'

doi: 10.3390/cells11223699
journal_title: Cells
journal_nlm_ta: Cells
publisher_name: MDPI

keywords:
- cancer stem cells
- non-coding RNAs
- EMT
- phenotypic and metabolic plasticity
- anti-cancer therapies

---
